Serving hundreds of leading biopharmaceutical companies globally:

Generated: May 20, 2019

DrugPatentWatch Database Preview

Details for Patent: 10,085,958

« Back to Dashboard

Which drugs does patent 10,085,958 protect, and when does it expire?

Patent 10,085,958 protects PROLENSA and is included in one NDA.

This patent has five patent family members in four countries.

Summary for Patent: 10,085,958

Title:	Bromfenac bioavailability
Abstract:	Formulations and methods that provided enhanced bromfenac penetration into ocular tissue when topically administered, compared to the currently available BROMDAY.TM. formulation and method when topically administered. The formulations and methods did so while retaining the patient convenience of a once-daily administration and advantageously lowered the bromfenac concentration dosed to the patient.
Inventor(s):	Padilla; Angel (Aliso Viejo, CA), Baklayan; George (Huntington Beach, CA)
Assignee:	BAUSCH & LOMB PHARMA HOLDINGS CORP. (Rochester, NY)
Application Number:	15/343,457
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 10,085,958
Prior Art and Litigation Support	Order Prior Art and Litigation support for Patent 10,085,958
Patent Claim Types: see list of patent claims

Drugs Protected by US Patent 10,085,958

Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Bausch And Lomb	PROLENSA	bromfenac sodium	SOLUTION/DROPS;OPHTHALMIC	203168-001	Apr 5, 2013		RX	Yes	Yes	➤ Sign Up	➤ Sign Up	Y				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate

International Family Members for US Patent 10,085,958

Subscribe to access the full database, or try a Free Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Canada	2852995	➤ Sign Up
European Patent Office	2765988	➤ Sign Up
Mexico	2014004347	➤ Sign Up
Mexico	348418	➤ Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.